Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population
Xueqing Yu, Nan Chen, Jun Xue, Chi Chiu Mok, Sang‐Cheol Bae, Xiaomei Peng, Wei Chen, Hong Ren, Xiao Li, Kajohnsak Noppakun, Jennifer Gilbride, Yulia Green, Beulah Ji, Chang Liu, Anuradha Madan, Mohamed Okily, Chun-Hang Tang, David A. Roth
Topics & Concepts
MedicineLupus nephritisBelimumabRenal functionInternal medicinePlaceboPopulationClinical endpointCreatinineUrologyRandomized controlled trialGastroenterologyImmunologyPathologyB-cell activating factorAlternative medicineAntibodyEnvironmental healthB cellDiseaseSystemic Lupus Erythematosus ResearchVagus Nerve Stimulation Researchinterferon and immune responses